EU Medicines Agency @EMA_News@respublicae.eu

📢EMA's human medicines committee recommended 14 new medicines for approval in the 🇪🇺, including:
☑️1 vaccine to protect against Respiratory Syncytial Virus #RSV
☑️7 medicines for #cancer
☑️1 medicine to prevent the transmission of #HIV
https://tinyurl.com/yu4kfmp3
#PublicHealth #CHMP https://t.co/EqT4HGfL10

🐦🔗: https://n.respublicae.eu/EMA_News/status/1682364425775325184

📢EU is stepping up action to prevent shortages of antibiotics for European #patients in the next winter season.
Read more in a statement published by EMA, @EU_Commission and the Heads of Medicines Agencies (HMA).
#antibiotics #shortages #PublicHealth https://www.ema.europa.eu/en/news/european-health-union-eu-steps-action-prevent-shortages-antibiotics-next-winter https://t.co/YL5OAcvSIV

🐦🔗: https://n.respublicae.eu/EMA_News/status/1680909442248855553

RT HaDEA
Check out the #EU4Health call for #tenders on #MentalHealth training and exchange programmes for more & better trained health professionals across the EU ⤵
Budget: €9M
Deadline: 4 September 2023
https://hadea.ec.europa.eu/news/eu4health-call-tenders-mental-health-training-and-exchange-programmes-health-professionals-2023-06-12_en
#HealthUnion https://t.co/1rWrZEBKSJ

🐦🔗: https://n.respublicae.eu/EU_HaDEA/status/1679784882543656960

RT ECDC
Thanks to vaccination:
- smallpox is now eradicated worldwide
- transmission of polio has ended in most parts of the world
- cervical and other cancers caused by HPV can be prevented
Find more on http://vaccination-info.eu#EUVaccinationPortal #vaccineswork #UnitedInProtection https://t.co/jeGBUxbhrm

🐦🔗: https://n.respublicae.eu/ECDC_EU/status/1679037976842518528

RT EURORDIS-Rare Diseases Europe
The deadline for the #RareBarometer survey on screening for rare diseases has been extended! 🥳
New deadline: 23rd July.
Use this opportunity to take the survey, if you haven’t already, or share it if you have!
Available here in 24 languages:
👉 http://tiny.cc/survey_NBS_RD https://t.co/r8eUGhbrKl

🐦🔗: https://n.respublicae.eu/eurordis/status/1678427941506629636

EMA's #safety committee, the #PRAC, carried out its work to assess all aspects of risk management related to the use of #medicines.
More information in our meeting highlights: https://www.ema.europa.eu/en/news/meeting-highlights-pharmacovigilance-risk-assessment-committee-prac-3-6-july-2023
#SafetyOfMedicines https://t.co/D0EHywwIMF

🐦🔗: https://n.respublicae.eu/EMA_News/status/1677261762968662016

📢 38 global regulators have published a statement confirming the good safety profile of #COVID19vaccines, including among children and people with underlying medical conditions, immunocompromised patients and pregnant women.
Read the full statement 👇
https://www.ema.europa.eu/en/news/global-regulators-confirm-good-safety-profile-covid-19-vaccines https://t.co/mq0KgP9G8T

🐦🔗: https://n.respublicae.eu/EMA_News/status/1676528487358685189

🎉 Happy 10th anniversary to EMA's Healthcare Professionals’ Working Party! 🎂
Thanks to all #HealthcareProfessionals for your invaluable contributions to EMA’s work. Our collaboration is key for shaping our understanding on the impact of regulatory decisions on patients’ lives. https://t.co/ysnvwCgebp

🐦🔗: https://n.respublicae.eu/EMA_News/status/1674341201657442304

RT EU HERA
Check out the new #EU4Health study sought by HERA! Key recommendations:
📌More preparedness in order to respond to serious cross-border threats to health
📌Secure vaccine production through direct capacity reservation
📌Coordinated approach to the initiatives of EU Member States https://n.respublicae.eu/EU_HaDEA/status/1671079565484064771
<div class="rsshub-quote">
HaDEA: Can flexible manufacturing help mitigate future health crises?
Find out in this #EU4Health study on the role of manufacturing flexibility in creating manufacturing capacities and responding to cross-border health threats
https://hadea.ec.europa.eu/programmes/eu4health/studies_en
#HealthUnion https://t.co/Bf8uuEj30Q
</div>

🐦🔗: https://n.respublicae.eu/EC_HERA/status/1674419876574928898

RT European Doctors
European doctors are pleased to celebrate 10 years of @EMA_News's Healthcare Professionals' Working Party
We look forward to many more years of contributing the medical profession’s point of view to ensuring the safety, availability &amp; affordability of medicines in Europe
#HCPWP https://t.co/cR3SW4ir5C

🐦🔗: https://n.respublicae.eu/CPME_EUROPA/status/1674001464497258496

RT HaDEA
Can flexible manufacturing help mitigate future health crises?
Find out in this #EU4Health study on the role of manufacturing flexibility in creating manufacturing capacities and responding to cross-border health threats
https://hadea.ec.europa.eu/programmes/eu4health/studies_en
#HealthUnion https://t.co/Bf8uuEj30Q

🐦🔗: https://n.respublicae.eu/EU_HaDEA/status/1671079565484064771

Veterinarians, what are your views regarding antimicrobial resistance &amp; #antibiotics used in animals 🐇🐖🐄?
Take part in our survey! Your input will help us to better inform everyone in Europe about #AMR and its threat.
📩 Feedback by 25 June
➡️https://ec.europa.eu/eusurvey/runner/AMRsurvey-Veterinarians-2023 https://t.co/8Nh1B1fqBZ

🐦🔗: https://n.respublicae.eu/EMA_News/status/1671125004468076545

#DYK that EMA has a dedicated office to address the specific needs of small companies? 🏢💊
By providing regulatory advice and training, we support SMEs that develop innovative medicines.
Find out more in the #SME office annual report 2022
➡️https://www.ema.europa.eu/en/documents/report/small-medium-sized-enterprise-sme-office-annual-report-2022_en.pdf https://t.co/uBMjW8Kwwr

🐦🔗: https://n.respublicae.eu/EMA_News/status/1671493310882430976

📢Just published! Read a new report how the EU medicines network collected, analysed and assessed safety data generated during the COVID-19 vaccination campaigns.
👉https://www.ema.europa.eu/en/news/report-how-eu-ensured-safety-medicines-during-covid-19
#COVID19 #vaccines https://t.co/tX8LEDoFGG

🐦🔗: https://n.respublicae.eu/EMA_News/status/1671819838149230592

What experience have we gained so far in conducting studies with real-world data to support EMA's regulatory decision making? 📊📉⚕️
Check out our new report to find out ⬇️ https://www.ema.europa.eu/en/news/use-real-world-evidence-regulatory-decision-making-ema-publishes-review-its-studies
#RealWorldData #BigData https://t.co/KBdAmqQwGh

🐦🔗: https://n.respublicae.eu/EMA_News/status/1672243938336428032

RT @SKyriakidesEU: I warmly welcome the adoption of our Recommendation on #AMR by #EPSCO Council, only two months after it was proposed.

We are taking decisive action in record time to tackle a growing health threat.

This is a strong #HealthUnion in action. https://t.co/HIurpO4xBx

🐦🔗: https://n.respublicae.eu/EMA_News/status/1668536557156937733

RT @EC_HERA: Clinical trials are the cornerstone to generate reliable info on the use of safe and effective medicines. Swift & coordinated response of clinical research to health threats is essential.

HERA presents at the lessons-learned workshop on Clinical Trials in Health Emergencies. https://t.co/RpvfAy7PDx

🐦🔗: https://n.respublicae.eu/EMA_News/status/1668230453097054216

📢 The highlights of our Management Board meeting are now available & include updates on:
✅approval of cancer medicines with potential to transform patient care
✅ recent initiatives on clinical trials in the EU
👉https://www.ema.europa.eu/en/news/ema-management-board-highlights-june-2023-meeting
#cancer #ClinicalTrials #patients

🐦🔗: https://n.respublicae.eu/EMA_News/status/1667151495219888130

At its June meeting, EMA's #safety committee, the #PRAC, carried out its work to assess all aspects of risk management related to the use of #medicines.

More information in our meeting highlights: https://www.ema.europa.eu/en/news/meeting-highlights-pharmacovigilance-risk-assessment-committee-prac-5-8-june-2023

#SafetyOfMedicines

🐦🔗: https://n.respublicae.eu/EMA_News/status/1667127819984306176

Just published!

A new scientific paper 📰on #clinicaltrial designs and statistical approaches applied in COVID-19 vaccine efficacy trials is now available.

It focuses on the first 4⃣ approved #COVID19vaccines.

Click to read the full paper 👇
https://doi.org/10.1080/19466315.2023.2211538.

🐦🔗: https://n.respublicae.eu/EMA_News/status/1666798759320211456